Healthcare
Live Price
Offline$1.87
+3.61% today
1Y Change
+157.14%
Window
Jun 27, 2025 → Jun 25, 2026
Coverage: 249 bars · Jun 27, 2025 → Jun 25, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Palisade Bio, Inc. (PALI) is a Healthcare stock with a market cap of $330.00M and listed on NASDAQ. The stock last traded around $1.86 and up 157.1% across the available one-year price window (Jun 27, 2025 → Jun 25, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +97.1%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +97.1%, free cash flow +11.0% with operating margin 0.0% and ROIC -13.9%. Stock Foundry combines PALI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
PALI
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
PALI Max Drawdown
-56.45%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PALI and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.